HPV16 E7 expression in skin induces TSLP secretion, type 2 ILC infiltration and atopic dermatitis-like lesions

dc.contributor.authorBergot, A.
dc.contributor.authorMonnet, N.
dc.contributor.authorLe Tran, S.
dc.contributor.authorMittal, D.
dc.contributor.authorAl-Kouba, J.
dc.contributor.authorSteptoe, R.
dc.contributor.authorGrimbaldeston, M.
dc.contributor.authorFrazer, I.
dc.contributor.authorWells, J.
dc.date.issued2015
dc.description.abstractAtopic dermatitis is a common pruritic and inflammatory skin disorder with unknown etiology. Most commonly occurring during early childhood, atopic dermatitis is associated with eczematous lesions and lichenification, in which the epidermis becomes hypertrophied resulting in thickening of the skin. In this study, we report an atopic dermatitis-like pathophysiology results in a murine model following the expression of the high-risk human papillomavirus (HPV) 16 oncoprotein E7 in keratinocytes under the keratin 14 promoter. We show that HPV16 E7 expression in the skin is associated with skin thickening, acanthosis and light spongiosis. Locally, HPV16 E7-expressing skin secreted high levels of thymic stromal lymphopoietin (TSLP) and contained increased numbers of innate lymphoid cells (ILCs). High levels of circulating immunoglobulin E were associated with increased susceptibility to skin allergy in a model of cutaneous challenge, and to airway bronchiolar inflammation, enhanced airway goblet cell metaplasia and mucus production in a model of atopic march. Surprisingly, skin pathology occurred independently of T cells and mast cells. Thus, our findings suggest that the expression of a single HPV oncogene in the skin can drive the onset of atopic dermatitis-like pathology through the induction of TSLP and type 2 ILC infiltration.
dc.description.statementofresponsibilityAnne-Sophie Bergot, Nastasia Monnet, Son Le Tran, Deepak Mittal, Jane Al-Kouba, Raymond J Steptoe, Michele A Grimbaldeston, Ian H Frazer, and James W Wells
dc.identifier.citationImmunology and Cell Biology, 2015; 93(6):540-547
dc.identifier.doi10.1038/icb.2014.123
dc.identifier.issn1440-1711
dc.identifier.issn1440-1711
dc.identifier.urihttp://hdl.handle.net/2440/97780
dc.language.isoen
dc.publisherNature Publishing Group
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/569938
dc.relation.granthttp://purl.org/au-research/grants/arc/FT110100372
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1043311
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1011203
dc.rights© 2015 Australasian Society for Immunology Inc.
dc.source.urihttps://doi.org/10.1038/icb.2014.123
dc.subjectT-Lymphocyte Subsets
dc.subjectMast Cells
dc.subjectSkin
dc.subjectAnimals
dc.subjectMice, Transgenic
dc.subjectMice
dc.subjectDermatitis, Atopic
dc.subjectDisease Models, Animal
dc.subjectInterleukins
dc.subjectCytokines
dc.subjectGene Expression
dc.subjectPhenotype
dc.subjectPapillomavirus E7 Proteins
dc.subjectImmunity, Innate
dc.subjectInterleukin-33
dc.subjectThymic Stromal Lymphopoietin
dc.titleHPV16 E7 expression in skin induces TSLP secretion, type 2 ILC infiltration and atopic dermatitis-like lesions
dc.typeJournal article
pubs.publication-statusPublished

Files